Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China
Objectives: To access the cost of illness, quality of life and work limitation in active ankylosing spondylitis (AS) patients using adalimumab in China.Methods: A prospective study was performed in 91 patients with active AS in China. Adult patients (aged ≥ 18 years) fulfilled the 1984 New York modi...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020-11-01
|
| coleção: | Frontiers in Public Health |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fpubh.2020.602334/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
